Asthma diagnosis using patient-reported outcome measures and objective diagnostic tests: now and into the future
| Autor: | Safia F, Nawaz, Mayuran, Ravindrarn, Merin E, Kuruvilla |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Current Opinion in Pulmonary Medicine. 28:251-257 |
| ISSN: | 1531-6971 1070-5287 |
| DOI: | 10.1097/mcp.0000000000000871 |
| Popis: | The global prevalence of asthma continues to increase; however, asthma remains under-diagnosed and under-treated. This results in a significant burden on the healthcare system and preventable patient morbidity and mortality. Over-diagnosis of asthma based on clinical history alone also complicates patient management. This heightens the importance of a prompt and accurate asthma diagnosis. Therefore, a review of the literature was performed regarding both objective diagnostic testing for asthma and using patient-reported outcome measures.The cornerstone of asthma diagnosis remains spirometry with testing for bronchodilator reversibility testing for pediatric and adult populations. This test may need to be repeated at multiple time points due to its low sensitivity. Peak flow measurement, fractional exhaled nitric oxide testing, and allergy testing are useful adjuncts to the diagnosis and phenotyping of asthma. Bronchoprovocation testing is reserved for people with high clinical suspicion for asthma, but negative spirometry. Novel noninvasive testing modalities may play a diagnostic role in the future. The advent of remote digital health monitoring technology has resulted in revisiting patient-reported outcome measures for the diagnosis and monitoring of asthma.Overall, improved diagnostic tools for asthma are crucial for earlier recognition and treatment of the disease and improved patient care outcomes worldwide. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|